Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management

NCT04567225 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

39

Enrollment

OTHER

Sponsor class

Stopped Stopped after internal review

Conditions

Diabetic Ketoacidosis
Type 1 Diabetes
Type 2 Diabetes

Interventions

DRUG: Early Glargine
DRUG: Late Glargine
OTHER: IV insulin infusion
OTHER: IV fluid and electrolytes replacement

Sponsor

The Cleveland Clinic